Estados financieros detallados de Modular Medical, Inc. (MODD): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $2.31, MODD presenta beneficios negativos (P/E no significativo) y un ROE del -292.14%. La capitalización bursátil es de $5M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.7M |
| Beneficio Bruto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$1.7M |
| I+D | 0 | $332642 | $1.9M | $3.0M | $4.1M | $7.7M | $9.1M | $12.9M | $14.7M | $20.0M |
| Generales y Administrativos | $91051 | $331661 | $694954 | $2.3M | $3.3M | $7.2M | $4.8M | $4.6M | $4.4M | $7.6M |
| Gastos Operativos | $91051 | $666164 | $2.6M | $5.3M | $7.3M | $14.9M | $13.9M | $17.5M | $19.0M | $25.9M |
| Beneficio Operativo | -$29418 | -$666164 | -$2.6M | -$5.3M | -$7.3M | -$14.9M | -$13.9M | -$17.5M | -$19.0M | -$27.6M |
| EBITDA | -$91051 | -$664303 | -$2.6M | -$5.3M | -$7.2M | -$15.8M | -$13.7M | -$17.0M | -$17.8M | -$25.9M |
| Gastos por Intereses | $15508 | 0 | 0 | 0 | $39791 | $2.8M | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$28456 | -$657646 | -$2.5M | -$5.3M | -$7.4M | -$18.6M | -$13.9M | -$17.5M | -$18.8M | -$28.2M |
| Impuestos | $800 | $1600 | $1589 | $1600 | $1600 | $1600 | $2000 | $2000 | $2000 | $2000 |
| Beneficio Neto | -$106559 | -$659246 | -$2.5M | -$5.3M | -$7.4M | -$18.6M | -$13.9M | -$17.5M | -$18.8M | -$28.2M |
| BPA | $-2.74 | $-4.50 | $-13.80 | $-26.70 | $-35.70 | $-82.20 | $-38.40 | $-23.40 | $-15.30 | $-12.36 |
| BPA Diluido | $-2.74 | $-4.50 | $-13.80 | $-26.70 | $-35.70 | $-82.20 | $-38.40 | $-23.40 | $-15.30 | $-12.36 |
| Acciones en Circulación (Diluidas) | $38889 | $148181 | $184329 | $198497 | $207052 | $226924 | $362684 | $745900 | $1.2M | $2.3M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$441000 | 0 |
| Beneficio Operativo | -$7.8M | -$7.2M | -$5.7M | -$6.5M |
| EBITDA | -$7.4M | -$6.9M | -$5.2M | -$6.0M |
| Beneficio Neto | -$7.8M | -$7.4M | -$6.4M | -$6.5M |
| BPA | $-4.20 | $-3.30 | $-1.37 | $-1.19 |
| BPA Diluido | $-4.20 | $-3.30 | $-1.37 | $-1.19 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Caja y Equivalentes | $1.4M | $4.3M | $6.6M | $3.1M | $1.5M | $9.1M | $3.8M | $9.2M | $13.1M | $6.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | $5000 | $147000 | $70000 | $17000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | $95000 | 0 | 0 | 0 |
| Activos Corrientes | $1.4M | $4.3M | $6.6M | $3.2M | $1.6M | $9.4M | $4.0M | $9.7M | $13.5M | $7.5M |
| Inmovilizado Material | 0 | $13259 | $75948 | $572258 | $499082 | $356652 | $3.2M | $4.1M | $5.2M | $7.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $213 | $180 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $1.4M | $4.3M | $6.7M | $3.9M | $2.2M | $9.8M | $7.2M | $13.8M | $18.7M | $14.8M |
| Cuentas por Pagar | 0 | 0 | $138314 | $367019 | $169284 | $299951 | $285000 | $802000 | $338000 | $992000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | $2.5M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $74420 | $15471 | $178929 | $661393 | $3.3M | $969699 | $979000 | $1.5M | $1.3M | $1.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $74420 | $15471 | $178929 | $980129 | $3.5M | $1.0M | $2.2M | $2.3M | $1.7M | $1.9M |
| Reservas | -$384400 | -$708663 | -$3.2M | -$8.6M | -$15.9M | -$34.6M | -$48.5M | -$65.9M | -$84.8M | -$113.0M |
| Patrimonio Neto | $1.3M | $4.3M | $6.5M | $2.9M | -$1.3M | $8.8M | $5.1M | $11.5M | $17.1M | $13.0M |
| Deuda Total | $21256 | $516 | 0 | $270950 | $2.8M | $184814 | $1.5M | $1.2M | $816000 | $393000 |
| Deuda Neta | -$1.4M | -$4.3M | -$6.6M | -$2.9M | $1.3M | -$8.9M | -$2.3M | -$8.0M | -$12.3M | -$6.5M |
| Capital Circulante | $1.3M | $4.3M | $6.4M | $2.5M | -$1.6M | $8.4M | $3.1M | $8.2M | $12.3M | $5.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $5.3M | $2.9M | $6.9M | $3.9M |
| Activos Totales | $13.0M | $10.3M | $14.8M | $12.3M |
| Pasivos Totales | $4.2M | $4.4M | $1.9M | $1.5M |
| Patrimonio Neto | $8.8M | $5.9M | $13.0M | $10.8M |
| Deuda Total | $611000 | $504000 | $393000 | $278000 |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Beneficio Neto | -$106559 | -$659246 | -$2.5M | -$5.3M | -$7.4M | -$18.63B | -$13.9M | -$17.5M | -$18.8M | -$28.2M |
| Amortizaciones | 0 | $1861 | $14468 | $35431 | $181841 | $117.5M | $152399 | $768000 | $1.1M | $1.7M |
| Compensación en Acciones | 0 | 0 | $532108 | $801244 | $1.2M | $4.03B | $2.7M | $2.7M | $2.4M | $1.8M |
| Cambio en Capital Circulante | $11749 | -$133746 | $165188 | $389359 | -$61147 | -$65.7M | -$211824 | -$94000 | -$392000 | $194000 |
| Flujo de Caja Operativo | -$94810 | -$791131 | -$1.8M | -$4.1M | -$5.9M | -$10.26B | -$11.0M | -$14.0M | -$15.7M | -$23.8M |
| Inversiones (CapEx) | 0 | -$15332 | -$77124 | -$260789 | -$109669 | -$54.8M | -$1.6M | -$1.7M | -$2.5M | -$3.9M |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | -$14098 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$94810 | -$806463 | -$1.9M | -$4.4M | -$6.0M | -$10.31B | -$12.6M | -$15.7M | -$18.2M | -$27.7M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$5.4M | -$7.2M | -$5.8M | -$6.0M |
| Inversiones (CapEx) | -$771000 | -$1.2M | -$1.0M | -$688000 |
| Flujo de Caja Libre | -$6.2M | -$8.4M | -$6.8M | -$6.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $813000 | $534000 | -$293000 | $447000 |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Crecimiento Beneficio Neto (anual) | | -518.7% | -285.2% | -109.5% | -38.7% | -152.5% | +25.5% | -25.9% | -7.8% | -50.0% |
| Crecimiento BPA (anual) | | -64.3% | -206.7% | -93.5% | -33.7% | -130.3% | +53.3% | +39.1% | +34.6% | +19.2% |
| Cambio en Acciones (anual) | | +281.0% | +24.4% | +7.7% | +4.3% | +9.6% | +59.8% | +105.7% | +65.4% | +85.2% |
| Crecimiento FCF (anual) | | -750.6% | -133.7% | -131.1% | -38.2% | -171281.3% | +99.9% | -23.7% | -16.4% | -52.0% |
| Tasa Impositiva Efectiva | -2.8% | -0.2% | -0.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| FCF por Acción | $-2.44 | $-5.44 | $-10.23 | $-21.94 | $-29.07 | $-45452.63 | $-34.88 | $-20.98 | $-14.76 | $-12.12 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $38889 | $148181 | $184329 | $198497 | $207052 | $226924 | $362684 | $745900 | $1.2M | $2.3M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -292.14% |
| Rentabilidad sobre capital invertido | -247.18% |
| Rentabilidad sobre activos | -228.73% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.03 |
| Ratio corriente | 3.25 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| P/E | -40.64 | -24.73 | -8.07 | -4.17 | -3.12 | -1.61 | -1.13 | -2.32 | -2.14 | -0.43 |
| P/VC | 3.33 | 3.82 | 3.17 | 7.68 | -18.07 | 3.39 | 3.11 | 3.51 | 2.36 | 0.93 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |